Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir after liver resection for HBV-related hepatocellular carcinoma
ACTRN12611000840987Phase 4Active, not recruiting
- Sponsor
- Third Affiliated Hospital of Naval Medical University
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of adefovir dipivoxil in hepatocellular carcinoma (HCC) and Chronic Hepatitis B (CHB) (2 arms), sponsored by Third Affiliated Hospital of Naval Medical University. Primary endpoints: Overall survival and Disease-free survival. Started May 2007; status: active, not recruiting.
02
Drugs
adefovir dipivoxil
03
Conditions
hepatocellular carcinoma (HCC)Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ACTRN12611000840987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000840987.